Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on May 27, 2025

Copper Lake Resources Ltd. Corporate Update
TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- Copper Lake Resources Ltd. (TSX-V: CPL, Frankfurt: WOI, OTC: WTCZF) (“Copper Lake” or the “Company”) announces that it will be seeking shareholder approval at the upcoming Annual General and Special Meeting of …

QCI’s CTO Andrew Cardno to Speak at C2G Conference on the Power of Analytic Theories in Bingo and Slots
SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI) is proud to announce that Andrew Cardno, Chief Technology Officer of QCI, will be a featured speaker at the upcoming Class 2 Gathering (C2G) Conference, taking place June 2–4, 2025 …

ControlUp Named a Leader in the 2025 Gartner® Magic Quadrant™ for Digital Employee Experience Management Tools for the Second Consecutive Year
SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- ControlUp, a global leader in Digital Employee Experience (DEX) management tools, today announced it has been named a Leader in the 2025 Gartner® Magic Quadrant™ for Digital Employee Experience Management …

iQor CXBPO™ Expands in Santa Rosa With a New State-of-the-Art CX Facility
FT. LAUDERDALE, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- iQor CXBPO™, an award-winning customer experience business process outsourcing (BPO) solutions provider, today announced the expansion of its operations in Santa Rosa, Philippines. The new facility …

TransAlta Renews Normal Course Issuer Bid
CALGARY, Alberta, May 27, 2025 (GLOBE NEWSWIRE) -- TransAlta Corporation (“TransAlta” or the “Company”) (TSX: TA) (NYSE: TAC) announced today that the Toronto Stock Exchange (“TSX”) has accepted the notice filed by the Company to implement a normal course …

Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June
TEL AVIV, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that members of its executive management team will present at two upcoming investor conferences in June as follows: Jefferies …

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …

BioAge Labs to Present at Upcoming Investor Conferences
EMERYVILLE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging …

ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
PRINCETON, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2025 Jefferies Global Healthcare Conference in New York City …

Zscaler to Accelerate Innovation in AI-Powered Security Operations with Acquisition of Red Canary
SAN JOSE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced it has signed a definitive agreement to acquire Red Canary, a recognized leader in Managed Detection and Response (MDR). With over …

BlackLine Announces Participation in Upcoming Investor Conferences
LOS ANGELES, May 27, 2025 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL) today announced that BlackLine’s management team will participate in the following upcoming investor conferences: Baird 2025 Global Consumer, Technology …

Microchip Technology to Present at the TD Cowen 53rd Annual Technology, Media & Telecom Conference
CHANDLER, Ariz., May 27, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the TD Cowen 53rd Annual …

Anaptys to Announce Updated Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, for Rheumatoid Arthritis on June 3, 2025
SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, will host an investor call and live webcast to review updated data from the global …

Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting
BURLINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric disorders, today announced an …

Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that Jason Okazaki, chief executive …

CarGurus to Present at William Blair’s 45th Annual Growth Stock Conference
BOSTON, May 27, 2025 (GLOBE NEWSWIRE) -- CarGurus, Inc. (Nasdaq: CARG), the No. 1 most visited digital auto platform for shopping, buying, and selling new and used vehicles1, today announced that Jason Trevisan, Chief Executive Officer, is scheduled to …

Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
SALT LAKE CITY, May 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will share data from seven new research studies at the 2025 ASCO Annual Meeting, including …

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Company announcement – No. 13 / 2025 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, May 27, 2025 – Zealand Pharma A/S ("the …

Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference
Daix (France), New York City (New York, United States), May 27, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of …

Inventiva Participera à la « Jefferies Global Healthcare Conference » et à la « UBS Spring Biotech Conference »
Daix (France), New York City (New York, Etats-Unis), le 27 mai 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de la …